Biotechgate is the global Business Development Database for the Biotech, Pharma and Medtech industries. 

Over 900,000 clinical trials 

60,000 company database 

Over 40,000 Biotech, Pharma and Medtech assets available for licensing 

Over 350,000 management contact details 

The latest M&A Deals Product pipelines 

In depth market research reports 

Dedicated investor database

At Cohesion Bureau we prepare life sciences companies for moments of growth, such as a financing, a listing or a first launch. Working alongside management and the IR and BD teams, we give strategic advice on the equity story to develop fresh ways to leverage announcements so that investors, partners and the media hear one cohesive message aligned with the company’s goals. By bringing communication into alignment with IR and business development Cohesion Bureau helps the company grow.

We act as a strategic advisor for companies spanning from seed stage through U.S. Nasdaq listings and beyond. We refine the strategy and tactics to increase visibility amongst investors, potential partners and the media. We support clients in identifying opportunities and executing strategic partnerships. 

Our senior team, based in the U.S., Switzerland, the U.K. and the EU, includes former executives from Novartis, Servier, HSBC Asset Management and LifeSci Advisors, as well as scientists and journalists from BioCentury, Reuters and RAI. Our clients include therapeutics, medical device and digital health companies, as well as specialist investment funds.

FreeMind is a consulting group whose goal is to assist in maximizing potential to receive funding from non-dilutive sources. Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. FreeMind's proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. 

Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH institutes, DoD, NSF, FDA, CDC, BARDA, etc., as well as private foundations. 

FreeMind's knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our team of experts will assist in making non-dilutive funding a key tool in a long-term financial strategy.

As a French biocluster, Lyonbiopole Auvergne-Rhône-Alpes is the gateway to healthcare innovation in Auvergne-Rhône-Alpes, France. It aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges.

MedNous is a print publication and a website for everyone involved in medical research in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical. 

The print publication analyses complex issues that life science professionals need to understand in order to bring their research into commercial development. These issues relate to regulatory affairs, patent law, government research policy and funding. The print publication appears 10 times per year and includes news, company interviews and commentary by corporate executives and other practicioners in this field.

Swiss Biotech unites the four leading biotech regions of Switzerland (BioAlps, BaselArea, Biopolo Ticino and Greater Zurich Area). The regions have early on combined efforts with the SWX Swiss Exchange which holds a leading position in terms of life-science listings and services. 

The National Industry Association named Swiss Biotech Association Represents more than 150 companies to date and acts as the operational arm for the marketing alliance. Swiss Biotech raises Switzerland’s profile as an economic center in Europe and profiles the biotech industry with its key research institutions and companies. Swiss Biotechs’ mission is to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of the drivers of biotechnology including research, education, economics, finance and industry. The bases for success in biotechnology are the critical mass of research institutes and accelerated technology transfer. The early integration of industry and well-trained workforce is another critical success factor for rapid economic growth. More than 40 technology parks throughout the country support the increasingly important and successful TechTransfer process.

Tiberend Strategic Advisors, Inc. is a corporate communications firm providing media strategy and execution for life science companies – biotech (therapeutics), medical devices and diagnostics. We work with both public and private emerging growth companies: 

1. To enhance valuation 

2. To build visibility for partnerships and strategic alliances

Since May 2000, VentureCapital Magazin has been informing investors, innovative entrepreneurs, and intermediaries about trends, transactions, and background information relating to private equity, entrepreneurship, and technology. Together with the online products VC-Magazin.de and the weekly Private Equity Flash, VentureCapital Magazine forms the leading private equity portal in the German-speaking world.

Explore our digital magazine.